MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by...

Area of Science:

• Neuroimmunology
• Molecular Biology
• Genetics

Background:

• B cells play a critical role in maintaining disease activity in relapsing multiple sclerosis (MS).
• Matrix metallopeptidase-9 (MMP-9) produced by B cells can disrupt the blood-brain barrier.
• MicroRNA-320a (miR-320a) is known to target MMP-9 mRNA.

Purpose of the Study:

• To investigate the expression levels of miR-320a and MMP-9 in B cells of MS patients.
• To determine the functional significance of miR-320a in regulating MMP-9 expression in B cells.

Main Methods:

• Analysis of MMP-9 protein and miR-320a expression in B lymphocytes from MS patients during relapse and remission.
• Functional study involving transfection of human B lymphocytes with a miR-320a inhibitor.

Main Results:

• MMP-9 protein expression was elevated, while miR-320a expression was significantly decreased in B cells of MS patients during relapse compared to remission.
• Inhibition of miR-320a in human B lymphocytes led to increased MMP-9 expression and secretion.

Conclusions:

• miR-320a expression is reduced in B cells of multiple sclerosis patients.
• This downregulation of miR-320a may contribute to increased blood-brain barrier permeability and neurological deficits in MS.